5 mg and 10 mg lyophilised tablets
rizatriptan
What Maxalt Rapitab is and what it is used for
MAXALT belongs to a class of drugs called selective serotonin 5HT 1B / 1D – receptor agonists.
Maxalt Rapitab is used to treat the headache phase of migraine attacks in adults.
Treatment with Maxalt Rapitab: Reduces the swelling of the blood vessels that surround the brain. This swelling causes headaches during a migraine attack.
What you need to know before you take Maxalt Rapitab
Do not take Maxalt Rapitab
- if you are allergic to rizatriptan benzoate or any of the other ingredients of this medicine (listed in section 6)
- if you have moderate or severe high blood pressure , or if you have slightly elevated blood pressure that is not treated with medication
- if you have or have ever had heart problems including heart attack or chest pain (angina) or if you have had symptoms of heart disease
- if you have severe liver or kidney disease
- if you have had a stroke (stroke) or mini- stroke ( transient ischemic attack, TIA )
- if you have problems with blood clots in your blood vessels ( peripheral vascular disease)
- if you are taking monoamine oxidase (MAO) inhibitors such as moclobemide, phenelzine, tranylcypromine or pargylin (antidepressants), or linezolid (an antibiotic ) or if it has been less than two weeks since you stopped using MAO inhibitors
- if you are currently taking ergotamine-type medicines, such as ergotamine or dihydroergotamine, to treat your migraine or methysergide to prevent migraine attacks
- if you are using another medicine from the same group, such as sumatriptan, naratriptan or zolmitriptan, to treat your migraine (see Other medicines and Maxalt Rapitab below).
If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before taking Maxalt Capital.
Warnings and cautions
Before taking Maxalt Rapitab, tell your doctor or pharmacist
- you have any of the following risk factors for heart disease: high blood pressure , diabetes , you are a smoker or use nicotine replacement therapy, there are cases of heart disease in the family, you are a man and over 40 years or you are a woman and have passed menopause
- you have impaired kidney or liver function
- you have a special type of heart rhythm problem (branch block)
- you have or have had any type of allergy
- your headache is associated with dizziness, difficulty walking, coordination difficulties or weakness in the arms and legs
- you are using any herbal remedy that contains St. John’s wort
- you have had an allergic reaction such as swelling of the face, lips, tongue and / or throat which may cause shortness of breath and / or difficulty swallowing ( angioedema )
- you take selective serotonin reuptake inhibitors ( SSRIs ) such as sertraline , escitalopram oxalate and fluoxetine or serotonin noradrenaline reuptake inhibitors ( SNRIs ) such as venlafaxine and duloxetine for depression
- you have had short-term symptoms including chest pain and tightness
If you take Maxalt Rapitab too often, it may result in you getting a chronic headache. In these cases, consult your doctor as you may need to stop taking Maxalt Capital.
Describe your symptoms to your doctor or pharmacist. Your doctor can determine if you are suffering from migraines. You should only take Maxalt Rapitab in case of a migraine attack. Maxalt Rapitab should not be used to treat headaches that may be due to other more serious conditions.
Tell your doctor if you are taking, have recently taken, or plan to take any other medicines, including medicines obtained without a prescription. This also applies to herbal remedies and the medications you normally take for your migraine. This is because Maxalt Rapitab may affect the effectiveness of certain medicines. Other medicines may also affect Maxalt Rapitab.
Other medicines and Maxalt Rapitab
Do not take Maxalt Rapitab
- if you are already taking a 5HT 1B / 1D – receptor agonist (sometimes referred to as ‘triptans’), such as sumatriptan, naratriptan or zolmitriptan.
- if you are using an MAOI such as moclobemide, phenelzine, tranycypromine, linezolid or pargylin or if it has been less than two weeks since you stopped using an MAOI .
- if you are taking ergotamine-type medicines, such as ergotamine or dihydroergotamine, to treat your migraine .
- if you are using methysergide to prevent migraine attacks.
Taking Maxalt Rapitab with the medicines listed above may increase the risk of side effects.
You should wait at least 6 hours after taking Maxalt Rapitab before taking ergotamine-type medicines such as ergotamine, dihydroergotamine, or methysergide.
You should wait at least 24 hours after taking ergotamine-type medicines before taking Maxalt Rapitab.
Ask your doctor for advice on how to take and the risks of taking Maxalt Rapitab
- if you are taking propranolol (see section 3: How to take Maxalt Rapitab).
- if you use SSRIs such as sertraline , escitalopramoxalate and fluoxetine or SNRIs such as venlafaxine and duloxetine for depression.
Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Maxalt Rapitab with food and drink
It may take longer for Maxalt Rapitab to work if taken after eating. Although it is better to take it on an empty stomach, you can still take it after a meal.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
It is not known if Maxalt Rapitab is harmful to the fetus if taken by a pregnant woman.
Breast-feeding should be avoided 24 hours after treatment.
Children and young people
The use of Maxalt Rapitab in children under 18 years of age is not recommended.
Use in patients older than 65 years
There are no complete studies of how safe and effective Maxalt is in patients older than 65 years.
Driving and using machines
You may feel drowsy or dizzy when using Maxalt Rapitab. Do not drive or use any tools or machines if this happens.
You are responsible for assessing whether you are fit to drive a motor vehicle or perform work that requires sharpened attention. One of the factors that can affect your ability in these respects is the use of drugs due to their effects and/or side effects. Descriptions of these effects and side effects can be found in other sections. Read all the information in this leaflet for guidance. If you are not sure, talk to your doctor or pharmacist.
Maxalt Rapitab contains aspartame
This medicine contains 1.88 mg aspartame in each 5 mg Rapitab tablet, equivalent to 1.1 mg phenylalanine. This medicine contains 3.75 mg aspartame in each 10 mg Rapitab tablet, equivalent to 2.1 mg phenylalanine.
Aspartame is a source of phenylalanine. It can be harmful if you have phenylketonuria (PKU), a rare, inherited disease that leads to the accumulation of high levels of phenylalanine in your body.
How to take Maxalt Rapitab
Maxalt Rapitab is used to treat migraine attacks. Take Maxalt Rapitab as soon as possible after your migraine attack. Do not use it to prevent an attack.
Always take this medicine exactly as your doctor has told you. Ask your doctor or pharmacist if you are unsure.
The usual dose is 10 mg.
If you are currently using propranolol or have a renal or hepatic impairment, you should use a 5 mg dose of one of Maxalt Rapitab. There should be at least two hours between taking propranolol and Maxalt Rapitab up to a maximum of 2 doses over 24 hours.
If migraine one returns within 24 hours
In some patients, migraine symptoms may return within 24 hours. If your migraine returns, you can take another dose. You should always allow at least two hours between doses.
If you still have migraines after two hours
If you do not respond to the first dose of one of Maxalt Rapitab during an attack, do not take a second dose of Maxalt Rapitab to treat the same attack. However, you will likely respond to Maxalt Rapitab during the next attack.
Do not take more than two doses of Maxalt Rapitab during the same 24-hour period (for example, do not take more than two 10 mg or 5 mg tablets or lyophilized tablets during 24 hours). There should be at least two hours between the dose limits.
Seek care if your condition worsens.
How to take Maxalt Rapitab
Maxalt Rapitab (rizatriptan benzoate) is available as 5 or 10 mg lyophilized tablets that dissolve in the mouth.
- Open Maxalt Rapitab’s blister pack with dry hands.
- The freeze-dried tablet is placed on the tongue, where it dissolves and can be swallowed together with the saliva.
- The lyophilised tablet can be used in situations when a drink is not available, or to avoid nausea and vomiting that may occur when taking tablets with liquid.
Maxalt is also available as tablets that are swallowed with liquid.
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may occur with this medicine.
In adult studies, the most commonly reported side effects were dizziness, drowsiness, and fatigue.
Common (affects less than 1 in 10 people)
- ant crawling ( paresthesias ), headache, decreased sensitivity to skin touch ( hypesthesia ), decreased mental acuity, insomnia
- fast or irregular heartbeat ( palpitation )
- redness (short-lived in the face)
- difficulty swallowing
- nausea, dry mouth , vomiting, diarrhea, stomach upset ( dyspepsia )
- feeling of heaviness in parts of the body, neck pain, stiffness
- abdominal or chest pain.
Uncommon (affects less than 1 in 100 people)
- bad taste in the mouth
- unsteady gait ( ataxia ), dizziness (dizziness), blurred vision, tremors, fainting ( syncope )
- confusion, nervousness
- high blood pressure ( hypertension ), thirst, feeling hot, sweating
- skin rash, itching and raised rash (hives), swelling of the face, lips, tongue and / or throat which may cause shortness of breath and / or difficulty swallowing ( angioedema ), shortness of breath ( dyspnoea )
- feeling of tightness in parts of the body, muscle weakness
- changes in heart rate or rate ( arrhythmia ), abnormalities on ECG (examination of the heart’s electrical activity), very fast heart rate ( tachycardia )
- facial pain, muscle pain.
Rare (affects less than 1 in 1,000 people)
- wheezing
- allergic reaction (hypersensitivity),sudden life-threatening allergic reaction ( anaphylaxis )
- stroke (this most often occurs in patients with risk factors for cardiovascular disease (high blood pressure , diabetes , smoking, use of nicotine replacement therapy, heart disease or stroke in the family, men over 40 years, postmenopausal women, special heart rhythm disorders (branch block))
- slow heartbeat (bradycardia).
Has been reported (occurs in an unknown number of users)
- myocardial infarction, spasm of the blood vessels of the heart (these usually occur in patients with risk factors for cardiovascular disease (high blood pressure , diabetes , smoking, use of nicotine replacement therapy, heart disease or stroke in the family, men over 40 years, postmenopausal women, special heart rhythm disorders) ))
- a so-called serotonergic syndrome that can cause side effects such as coma , unstable blood pressure , extremely high body temperature, disturbance in the coordination of muscle movements, anxiety and hallucinations
- severe skin rash with or without fever ( toxic epidermal necrolysis )
- cramp (seizure)
- spasm of blood vessels in the arms and legs including feeling cold and numbness of the hands and feet
- spasm in the blood vessels of the colon which can cause abdominal pain.
Contact a doctor immediately if you experience symptoms of an allergic reaction, serotonergic syndrome, heart attack, or stroke.
Also, contact your doctor if you notice any symptoms that may indicate an allergic reaction (such as a rash or itching ) after taking Maxalt Rapitab.
How to store Maxalt Rapitab
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton/plastic case/sachet/blister after “EXP” or “EXP”. The expiration date is the last day of the specified month.
Store Maxalt Rapitab at a maximum of 30 ° C.
Store in the original package. Moisture sensitive.
Do not remove the blister with the lyophilized tablet from the aluminum bag until you are ready to take the medicine. Do not use this medicine if you notice that the sachet is damaged.
Always store the aluminum bag in the smaller box.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Contents of the pack and other information
Content declaration
The active substance in Maxalt is rizatriptan. One lyophilized tablet contains 5 and 10 mg of rizatriptan, respectively, corresponding to 7.265 and 14.53 mg of rizatriptan benzoate, respectively.
The other ingredients in Maxalt Rapitab are gelatin, mannitol (E421), glycine, aspartame (E951), peppermint flavor (consisting of peppermint oil, maltodextrin, and dextrin).
What the medicine looks like and contents of the pack
A maximum of 5 mg lyophilized tablets are white to off-white, round with a triangle on one side, and have a peppermint taste.
A maximum of 10 mg lyophilized tablets are white to off-white, round with a square on one side, and have a peppermint taste.
Pack sizes: 2, 3, 6, 12, or 18 freeze-dried tablets.
Not all pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorisation Holder
NV Organon
Kloosterstraat 6
5349 AB Oss
Netherlands
Manufacturer
Merck Sharp & Dohme BV.
Waarderweg 39
2031 BN Haarlem
Netherlands
This medicinal product is authorized under the European Economic Area under the names:
| Maxalt Rapitab 5 mg lyophilised tablets | |
| Austria, Finland, Sweden | MAXALT RAPITAB |
| Belgium, Luxembourg | MAXALT LYO 5 mg |
| Denmark | MAXALT Melt, orodispersible tablets |
| Germany | MAXALT lingua 5 mg orodispersible tablets |
| Greece | MAXALT Rapid Sol. Tab. |
| Iceland | MAXALT MELT 5 mg lyophilized tablets |
| Ireland | Rizatriptan MSD 5 mg oral lyophilisates |
| Italy | MAXALT RPD 5 mg oral lyophilized |
| Netherlands | MAXAL MELT |
| Norway | Maxalt Capital |
| Poland | MAXALT RPD |
| Romania | Maximum 5 mg oral liophilizate |
| Maxalt Rapitab 10 mg lyophilised tablets | |
| Austria, Finland, Sweden | MAXALT RAPITAB |
| Belgium, Luxembourg | MAXALT LYO 10 mg |
| Denmark | MAXALT Melt, orodispersible tablets |
| France | MAXALTLYO |
| Germany | MAXALT lingua 10 mg orodispersible tablets |
| Greece | MAXALT Rapid Sol. Tab. |
| Iceland | MAXALT MELT 10 mg lyophilized tablets |
| Ireland | Rizatriptan MSD 10 mg oral lyophilisates |
| Italy | MAXALT RPD 10 mg oral lipophilic |
| Lithuania | MAXALT 10 mg geriamieji liofilizatai |
| UK | MAXAL MELT |
| Netherlands | MAXAL MELT |
| Norway | Maxalt Rapitab |
| Poland | MAXALT RPD |
| Romania | Maxalt 10 mg oral liophilizate |
| Spain | MAXALT MAX 10 mg |